menu search

J&j, p&g sued after fda panel ruling on cold medicine decongestant

A new lawsuit accuses Johnson & Johnson and Procter & Gamble of deceiving consumers about decongestant cold me...

September 14, 2023, 12:58 pm

Nvidia and amgen back ai drug developer generate:biomedicines' $273m financing

Generate:Biomedicines said it has raised $273 million to fund its pipeline of programs in preclinical a...

September 14, 2023, 11:29 am

Nvidia, amgen back ai-driven drug firm generate:biomedicines' $273 mln fundraise

Drug developer Generate:Biomedicines, which uses artificial intelligence (AI) to find new treatments, said on Thursday it has raised $273 million from...

September 14, 2023, 8:41 am

Gsk opens new site in uk unlike rival astrazeneca

GSK has opened a new £65 million drug factory in Hertfordshire in a move it said would enable rapid production of ...

September 14, 2023, 8:22 am

Biohacking market poised to attain usd 83 billion by 2032 | north america hold – highest revenue share of 39%

The market for genetic modification kits is growing because more and more companies are developing these kits. These companies are doing research and ...

September 13, 2023, 1:37 pm

Decongestant found in many cold, allergy medicines doesn't actually work, fda advisors say

In a unanimous vote, advisors said oral versions of phenylephrine – a nasal decongestant found in versions of drugs like Nyquil and Benadryl – isn...

September 12, 2023, 12:48 pm

Here's why you should add ani pharmaceuticals (anip) to your portfolio

ANI Pharmaceuticals (ANIP), a top-ranked stock, has a diverse portfolio of rare disease and generic medicines. Its Purified Cortrophin Gel is witnessi...

September 11, 2023, 3:47 pm

Nurix (nrix) stock increases 9% in a month: here's why

The upside in Nurix's (NRIX) shares can be attributed to the company's recently signed collaboration with Seagen (SGEN) to develop a new class of ...

September 11, 2023, 1:32 pm

Pfizer vs. gilead sciences: covid-19 battle of pharma titans

Wall Street underestimates the prospects of Pfizer and Gilead Sciences, given their significant role in developing vaccines and ...

September 9, 2023, 3:17 am

Recursion pharmaceuticals has a prescription for high drug costs: ai and 25 petabytes of data

Amid fierce debate about prescription-drug prices and countless proposals to rein them in, there has been a point of widespread agreement: Those price...

September 8, 2023, 12:38 pm

1 top pharma growth stock to buy today and hold forever

Vertex Pharmaceuticals has many avenues for chasing growth both big and small. Its cystic fibrosis medicines <...

September 8, 2023, 10:15 am

The 3 best pharma stocks to buy now: september 2023

The pharmaceutical sector will always be a sector in constant evolution and growth. As technology advances, the companies that make life in this secto...

September 8, 2023, 9:14 am

: medicare patients paid 4 times as much as their drug plans for certain medicines, study finds 

People with diabetes, asthma, and other conditions often pay higher prescription costs that effectively subsidize healthier plan enrollees, researcher...

September 7, 2023, 3:56 pm

Infi stockholders should contact robbins llp for information about the class action involving infinity pharmaceuticals, inc.

SAN DIEGO, Sept. 06, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities...

September 6, 2023, 9:26 pm

60 degrees pharmaceuticals to participate in h.c. wainwright 25th annual global investment conference

Management investor presentation webcast available Monday 9/11, 7:00 AM ET Attendees may request 1 x 1 meetings with management at [email protected] ...

September 6, 2023, 11:31 am

Bridgebio pharma announces positive feedback from the u.s. fda and eu ema on the regulatory path for a pivotal phase 3 trial of infigratinib in children with achondroplasia

– BridgeBio completed an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA), and a scientific advice engagement with the Europe...

September 6, 2023, 11:30 am

Uk joins eu in approving xbb.1.5 jab from pfizer-biontech, but others subvariants are emerging

An updated Covid-19 vaccine made by Pfizer Inc (NYSE:PFE) and BioNTech has been approved by the UK medical regulator, amid a rise in new variants and ...

September 6, 2023, 9:47 am

Nuvectis: early stage company that's low on cash

Nuvectis is developing precision medicines for cancer patients, with lead asset NXP800 targeting ARID1a...

September 6, 2023, 8:03 am

60 degrees pharmaceuticals to participate in h.c. wainwright 25th annual global investment conference

WASHINGTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals Inc. (“60P” or the “Company”) (Nasdaq: SXTP ), a pharmaceutical comp...

September 6, 2023, 7:31 am

Solid biosciences to participate at upcoming investor conferences

CHARLESTOWN, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic ...

September 5, 2023, 12:56 pm


Search within

Pages Search Results: